大行評級 | 花旗將廣汽H股連升兩級至買入,稱爲中國新能源汽車界最好的國有企業
彭博新聞社報道,花旗將廣汽集團H股評級由賣出上調至買入,稱其爲中國新能源汽車領域最好的國有企業,將受益於利潤前景的大幅改善和產品週期的升級。
分析師Jeff Chung等在報告中指出,廣汽集團新能源汽車業務本季度應能 實現收支平衡,並預計公司至2022年淨利潤將增長22%-65%。
預計共七款新能源汽車銷量到2021年將增長45%。
廣汽與豐田和本田的中國合資企業 在2021年不會失去市場份額。
上調H股目標價上調240%至13.09港元,週一收盤報9港元。
上調A股目標159%至11.9元人民幣,但較週一收盤低12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.